Board of Directors
Gordon Sato, PhD | Co-Founder & Chairman of the Board, A&G Pharmaceutical
Lars Hanan, MBA | Co-Founder and Managing Partner, BroadOak Capital Partners
Tom Hancock | Principal, New England Partners/Nexus Medical Partners Fund
SeungSuh “Stanley” Hong, PhD | Vice President of Business Development, Celltrion
Jennie Mather, PhD | Senior Vice President, Stem Cell Research, MacroGenics
Ginette Serrero, PhD | Co-Founder and CEO
Seung Il-Shin, PhD | Founder, Celltrion
Dr. Shin founded and oversees business development for Celltrion, and he serves on the company’s board of directors. In addition, he is Senior Advisor for International Development for VaxGen, with responsibility for organizing worldwide distribution of the company’s vaccines and other products. Previously, Dr. Shin founded and directed an international initiative for the United Nations that ultimately led to the establishment of the International Vaccine Institute located in Seoul, Korea. In 1984, Dr. Shin co-founded and served as CEO of Eugene Tech International, where he led the company’s effort to develop and market a hepatitis B vaccine that was eventually distributed in many developing countries. He also served as Senior Executive Vice President and Director of the R&D Laboratories of Cheil Sugar & Co. in Seoul. Before that, Dr. Shin was a Professor of Genetics at Albert Einstein College of Medicine in New York, and he was a founding member of the Basel Institute of Immunology. Dr. Shin received a BS in Chemistry and a PhD in Biochemistry from Brandeis University.
Gordon Sato, PhD | Co-Founder & Chairman of the Board, A&G Pharmaceutical
Lars Hanan, MBA | Co-Founder and Managing Partner, BroadOak Capital Partners
Tom Hancock | Principal, New England Partners/Nexus Medical Partners Fund
SeungSuh “Stanley” Hong, PhD | Vice President of Business Development, Celltrion
Jennie Mather, PhD | Senior Vice President, Stem Cell Research, MacroGenics
Ginette Serrero, PhD | Co-Founder and CEO
Seung Il-Shin, PhD | Founder, Celltrion
Dr. Shin founded and oversees business development for Celltrion, and he serves on the company’s board of directors. In addition, he is Senior Advisor for International Development for VaxGen, with responsibility for organizing worldwide distribution of the company’s vaccines and other products. Previously, Dr. Shin founded and directed an international initiative for the United Nations that ultimately led to the establishment of the International Vaccine Institute located in Seoul, Korea. In 1984, Dr. Shin co-founded and served as CEO of Eugene Tech International, where he led the company’s effort to develop and market a hepatitis B vaccine that was eventually distributed in many developing countries. He also served as Senior Executive Vice President and Director of the R&D Laboratories of Cheil Sugar & Co. in Seoul. Before that, Dr. Shin was a Professor of Genetics at Albert Einstein College of Medicine in New York, and he was a founding member of the Basel Institute of Immunology. Dr. Shin received a BS in Chemistry and a PhD in Biochemistry from Brandeis University.
© 2009 A&G Pharmaceutical, Inc. All Rights Reserved. | Terms of Use | Privacy
